Using Virtual Reality Environments to Augment Cognitive Behavioral Therapy for Fears and Phobias in Autistic Adults.

ASD adults anxiety autism cognitive behavior therapy fear phobia virtual reality

Journal

Autism in adulthood : challenges and management
ISSN: 2573-959X
Titre abrégé: Autism Adulthood
Pays: United States
ID NLM: 101741462

Informations de publication

Date de publication:
01 Jun 2019
Historique:
entrez: 30 4 2019
pubmed: 30 4 2019
medline: 30 4 2019
Statut: ppublish

Résumé

Fears and phobias are common in people on the autism spectrum and can impact on their ability to undertake usual daily activities. Graded exposure to the anxiety-provoking stimulus is a recognized method of treatment for fears/phobias in the nonautistic population but may pose specific difficulties for autistic people. For example, real-life exposure can be too anxiety-provoking to allow treatment to take place, and imaginal exposure can be problematic. To address this, we developed an intervention that combines cognitive behavioral therapy (CBT) with immersive virtual reality (VR) exposure to reduce anxiety. Following successful trials of this intervention with young people on the autism spectrum, we report a pilot study using the same intervention with autistic adults. Eight adults (aged 18-57 years) received one psychoeducation session and then four 20-minute sessions of graded exposure with a therapist in an immersive VR room (known as the Blue Room). Each participant completed all sessions showing that the intervention is feasible and acceptable. Outcomes were monitored at 6 weeks and 6 months postintervention. Five of the eight participants were classified as intervention responders and at 6 months after the end of intervention were experiencing real-life functional improvements. These preliminary findings show that VR-graded exposure alongside CBT may be an effective treatment for autistic people with phobias. Why was this study done?Anxiety is common in autistic adults. For some people, fears and phobias regarding everyday objects and situations occur frequently affecting everyday life. The main method to treat fears and phobias for people without autism is gradual exposure to the situation that causes anxiety. However, this method may be challenging for people on the autism spectrum. We wanted to test a new method of treatment that uses cognitive behavioral therapy (CBT) delivered with gradual exposure in a fully immersive virtual reality (VR) environment.What was the purpose of this study?We have already delivered this treatment successfully with autistic children. We wanted to test if this treatment would work for autistic adults. Changing traditional psychological treatments, such as CBT, to make it more suitable for autistic people is recommended by the National Institute for Health and Care Excellence.What did the researchers do?We recruited eight autistic adults (aged 18-57 years) with a fear/phobia and their supporter (parent/friend/support worker). Each adult had one session with a therapist to learn anxiety management techniques. They then had four 20-minute sessions of graded exposure with a therapist in an immersive VR room (known as the Blue Room). Each participant had a computer-generated scene designed for their specific anxiety-provoking situation. After four sessions, the participant tried real-life exposure with their supporter. We measured progress at 6 weeks and 6 months after the last VR session.What were the results of this study?Each participant completed all four sessions. This shows that the intervention was possible to deliver and acceptable to autistic people and therapists. Participants completed assessments at 6 weeks and 6 months after the VR sessions. Five of the eight participants were "responders" to the intervention. This means that 6 months after the last VR session, they still had real-life day-to-day improvements in relation to their phobia.What do these findings add to what was already known?We had not delivered this intervention to autistic adults previously. The findings show that this VR intervention has the potential to be an effective treatment for anxiety in autistic adults.What are the potential weaknesses in the study?This is a small study and future work will be a larger trial of this treatment-comparing results from people who get the intervention with people who do not. We would also want to have an outcome assessor who did not know whether people had received the intervention or not.How will these findings help autistic adults now or in the future?This new intervention has the potential to help autistic adults manage their anxiety in stressful situations and therefore may improve their quality of life.

Identifiants

pubmed: 31032480
doi: 10.1089/aut.2018.0019
pii: 10.1089/aut.2018.0019
pmc: PMC6485262
doi:

Types de publication

Journal Article

Langues

eng

Pagination

134-145

Subventions

Organisme : Medical Research Council
ID : MC_PC_14101
Pays : United Kingdom

Déclaration de conflit d'intérêts

J.R.P. has an application for patent WO/2014/177875 Apparatus in the performance of cognitive behavior therapy and method of performance with royalties paid to Third Eye. All other authors have no conflict of interests.

Références

J Am Acad Child Adolesc Psychiatry. 2003 Dec;42(12):1443-50
pubmed: 14627879
Clin Psychol Rev. 2008 Dec;28(8):1400-12
pubmed: 18783862
Autism Res. 2008 Jun;1(3):193-7
pubmed: 19360666
Br J Dev Psychol. 2009 Jun;27(Pt 2):425-44
pubmed: 19998539
Res Dev Disabil. 2011 Sep-Oct;32(5):1910-7
pubmed: 21515028
Clin Child Fam Psychol Rev. 2011 Sep;14(3):302-17
pubmed: 21735077
J Autism Dev Disord. 2013 Apr;43(4):851-9
pubmed: 22895777
J Autism Dev Disord. 2013 Jun;43(6):1314-25
pubmed: 23076506
Neuropsychology. 2014 Jan;28(1):55-67
pubmed: 24015827
J Clin Psychiatry. 2013 Nov;74(11):1093-100
pubmed: 24330896
PLoS One. 2014 Jul 02;9(7):e100374
pubmed: 24987957
Autism. 2015 Oct;19(7):814-23
pubmed: 25911091
J Autism Dev Disord. 2016 Jun;46(6):1916-1930
pubmed: 26861713
Psychol Med. 2017 Jul;47(10):1744-1760
pubmed: 28222820
Harv Rev Psychiatry. 2017 May/Jun;25(3):103-113
pubmed: 28475502
Depress Anxiety. 2018 Jun;35(6):502-514
pubmed: 29451967
J Autism Dev Disord. 2019 May;49(5):1912-1927
pubmed: 30767156

Auteurs

Morag Maskey (M)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.

Jacqui Rodgers (J)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.

Barry Ingham (B)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.
Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Mark Freeston (M)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.

Gemma Evans (G)

Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Marie Labus (M)

Business Development and Enterprise, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom.

Jeremy R Parr (JR)

Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, United Kingdom.
Northumberland, Tyne and Wear NHS Foundation Trust, Newcastle upon Tyne, United Kingdom.

Classifications MeSH